Man Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,540
| Closed | -$318K | – | 2610 |
|
|
2025
Q4 | $318K | Sell |
3,540
-18,551
| -84% | -$1.76M | ﹤0.01% | 2004 |
|
|
2025
Q3 | $2.18M | Sell |
22,091
-93,909
| -81% | -$9.31M | ﹤0.01% | 1388 |
|
|
2025
Q2 | $10.6M | Buy |
116,000
+111,732
| +2,618% | +$10.8M | 0.02% | 760 |
|
|
2025
Q1 | $483K | Sell |
4,268
-46,888
| -92% | -$5.02M | ﹤0.01% | 1807 |
|
|
2024
Q4 | $5.4M | Sell |
51,156
-42,392
| -45% | -$4.55M | 0.01% | 985 |
|
|
2024
Q3 | $10.1M | Sell |
93,548
-378,015
| -80% | -$41.3M | 0.03% | 740 |
|
|
2024
Q2 | $51.2M | Buy |
471,563
+340,305
| +259% | +$40.1M | 0.13% | 178 |
|
|
2024
Q1 | $17.3M | Sell |
131,258
-149,345
| -53% | -$18.7M | 0.04% | 476 |
|
|
2023
Q4 | $34.1M | Buy |
+280,603
| New | +$31.3M | 0.1% | 245 |
|
|
2023
Q3 | – | Sell |
-288,643
| Closed | -$36.7M | – | 228 |
|
|
2023
Q2 | $42M | Buy |
+288,643
| New | +$39.2M | 0.13% | 179 |
|
|
2023
Q1 | – | Sell |
-2,898
| Closed | -$364K | – | 513 |
|
|
2022
Q4 | $369K | Buy |
+2,898
| New | +$336K | ﹤0.01% | 1594 |
|
|
2022
Q2 | – | Sell |
-80,861
| Closed | -$10.3M | – | 2450 |
|
|
2022
Q1 | $10.3M | Sell |
80,861
-15,092
| -16% | -$1.82M | 0.04% | 598 |
|
|
2021
Q4 | $11.8M | Sell |
95,953
-121,519
| -56% | -$15.9M | 0.04% | 529 |
|
|
2021
Q3 | $30.9M | Buy |
217,472
+21,422
| +11% | +$3.15M | 0.11% | 210 |
|
|
2021
Q2 | $30.6M | Buy |
196,050
+151,116
| +336% | +$24.5M | 0.11% | 206 |
|
|
2021
Q1 | $6.98M | Buy |
44,934
+19,176
| +74% | +$2.97M | 0.03% | 559 |
|
|
2020
Q4 | $3.85M | Sell |
25,758
-1,669
| -6% | -$236K | 0.02% | 940 |
|
|
2020
Q3 | $3.63M | Buy |
+27,427
| New | +$3.58M | 0.01% | 967 |
|
|
2020
Q2 | – | Sell |
-56,444
| Closed | -$5.54M | – | 1842 |
|
|
2020
Q1 | $5.54M | Sell |
56,444
-247,673
| -81% | -$32.5M | 0.04% | 466 |
|
|
2019
Q4 | $44.2M | Sell |
304,117
-253,281
| -45% | -$35M | 0.15% | 150 |
|
|
2019
Q3 | $74.3M | Sell |
557,398
-229,582
| -29% | -$29.7M | 0.28% | 77 |
|
|
2019
Q2 | $90M | Buy |
786,980
+416,639
| +113% | +$48.8M | 0.33% | 49 |
|
|
2019
Q1 | $45.9M | Buy |
370,341
+122,805
| +50% | +$14M | 0.17% | 125 |
|
|
2018
Q4 | $24.9M | Sell |
247,536
-91,947
| -27% | -$10.3M | 0.11% | 196 |
|
|
2018
Q3 | $43.3M | Buy |
339,483
+79,521
| +31% | +$9.46M | 0.16% | 118 |
|
|
2018
Q2 | $28.1M | Buy |
259,962
+116,865
| +82% | +$12.7M | 0.12% | 177 |
|
|
2018
Q1 | $15.1M | Buy |
+143,097
| New | +$16.6M | 0.07% | 313 |
|
Other funds holding ZBH
Man Group's ZBH Position: Q1 2026 in Review
Man Group sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 3,540 shares — an estimated $318K sold.
Man Group first reported a position in ZBH in Q1 2018 and held it in 27 quarters. The position peaked at $90M in Q2 2019. 916 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Man Group reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
- Man Group sold 3,540 Zimmer Biomet shares in Q1 2026, an estimated $318K.
- Man Group first reported a position in Zimmer Biomet in Q1 2018 and held it in 27 quarters.
- Man Group's Zimmer Biomet position peaked at $90M in Q2 2019.
- 916 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.